Upcoming FDA Reorg Overhauls Office of Regulatory Affairs

The US FDA hopes to make major changes in 2024, including an inspections-focused replacement for the Office of Regulatory Affairs, a new Office of the Chief Medical Officer, and moving labs currently within ORA to the Office of the Chief Scientist.

FDAEntrance_1200x675

Prepare to say goodbye to the Office of Regulatory Affairs and hello to the Office of Inspections and Investigations in 2024.

The renaming is one component of a reorganization announced by the US Food and Drug Administration on Wednesday, which the...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation